ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
Jeffrey L. Bennett, Peter Rieckmann, Xavier Montalbane, Daniel Mikol, Ulrich Freudensprung, Thomas Plitz, Johan van Beek, for the ATON Trial Group, Journal of Neurologic Science, 1/1/2015Segmental Analysis of Macular Layers in Patients with Unilateral Primary Open-Angle Glaucoma
Zangalli C, Ahmed O, Waisbourd M, et al, Journal of Glaucoma, 1/1/2015Simultaneous, bilateral ophthalmoplegia as the presenting sign of paediatric multiple sclerosis: Case report and discussion of the differential diagnosis
Adam MK, Krespan K, Moster ML, Neuro-Ophthalmology, 1/1/2014
